Logo FCSQ English

Pilot Project to Screen, Raise Awareness and Determine Cognitive and Emotional Responses

Share

Share on social media

Pilot Project to Screen, Raise Awareness and Determine Cognitive and Emotional Responses
Year(s)
2016-2019
Invested Amount
$350,000

Project

CIUSSS de l’Est-de-l’Île-de-Montréal

Pilot project of a multidimensional procedure for women affected by breast cancer who are struggling with cognitive impairment associated with oncological treatments. 

Description

In spite of the constant advancements in cancerology, oncology treatments administered to women with breast cancer still cause serious adverse effects. Some of these effects are less well known and, consequently, not properly evaluated or adequately relieved by medical teams. One of these effects is related to cognitive functioning. Oncological treatments may sometimes cause cognitive impairment affecting the working memory, attentional processes, the ability to multitask, the alternation ability, cognitive flexibility and information processing speed. According to published studies, the prevalence of cognitive impairment in these patients could be as high as 60%.

In this respect, the team at CIUSSS de l’Est-de-l’Île-de-Montréal would like to set up an essential and innovative pilot project in Quebec, to screen, raise awareness and determine cognitive and emotional responses, in order to solve these difficulties.

The project will be drafted and set up by a multidisciplinary team and will include four components:

  1. awareness and education: educational workshops for patients and their loved ones, staff training;
  2. screening: integrate a screening tool of the cognitive complaint and a decision algorithm to refer patient to a multidimensional memory workshop, based on the seriousness of the complaint;
  3. evaluation and intervention: cognitive skills assessment through a neuropsychological evaluation, followed by a multidimensional memory workshop;
  4. information: draw up an information and strategy handbook on how to deal with cognitive impairment resulting from oncological treatments